Drawing based on the label description. No photo yet.
AD pill
Pill with imprint AD is yellow, round, 8 mm and has been identified as Spironolactone 25 mg. It is used for high blood pressure, heart failure and swelling from fluid buildup. It is supplied by Denton Pharma, Inc. Dba Northwind Pharmaceuticals.
Spironolactone 25 mg
- Imprint
- AD
- Strength
- 25 mg
- Used for
- High blood pressure, heart failure and swelling from fluid buildup
- Color
- Yellow
- Shape
- Round
- Size
- 8 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Denton Pharma, Inc. Dba Northwind Pharmaceuticals
- Drug class
- Aldosterone blocker (heart and blood pressure medicine)
- NDC
- 70934-256, 16729-225, 70934-256-30, 70934-256-90, 61919-772, 61919-772-30, 61919-772-90, 50090-3747, 50090-3747-6, 50090-3747-0, 50090-3747-1, 71205-146, 71205-146-30, 71205-146-60, 71205-146-90, 53002-4720, 53002-4720-0, 76420-062, 76420-062-30, 76420-062-60, 76420-062-90, 76420-062-01, 43063-832, 43063-832-30, 43063-832-60, 43063-832-90, 43063-832-01, 68071-3375, 68071-3375-3, 68071-3375-6, 68071-3375-9, 68071-3375-1, 68071-3375-8, 67046-1117, 67046-1117-3, 70518-1314, 70518-1314-0, 70518-1314-1, 70518-1314-2, 70518-1314-4
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Spironolactone used for?
Spironolactone is used for high blood pressure, heart failure, swelling from fluid buildup and low potassium.
- Medicine type
- Aldosterone blocker (heart and blood pressure medicine)
Official uses from the US prescribing label
Heart Failure
Spironolactone tablets are indicated for treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure.
Spironolactone tablets are usually administered in conjunction with other heart failure therapies.
Hypertension
Spironolactone tablets are indicated as add-on therapy for the treatment of hypertension, to lower blood pressure in patients who are not adequately controlled on other agents. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Edema Associated with Hepatic Cirrhosis or Nephrotic Syndrome
Spironolactone tablets are indicated for the management of edema in the following settings:
- Cirrhosis of the liver when edema is not responsive to fluid and sodium restriction.
- Nephrotic syndrome when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics produce an inadequate response.
Because it increases serum potassium, spironolactone tablets may be useful for treating edema when administration of other diuretics has caused hypokalemia.
Primary Hyperaldosteronism
Spironolactone tablets are indicated in the following settings:
- Short-term preoperative treatment of patients with primary hyperaldosteronism.
- Long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are not candidates for surgery.
- Long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).
From the FDA-approved label on DailyMed (published Oct 05, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows AD.
- It is yellow, round, 8 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Spironolactone
Inactive: Lactose Monohydrate, Dibasic Calcium Phosphate Dihydrate, Povidone K25, Peppermint Oil, Talc, Starch, Corn, Silicon Dioxide, Magnesium Stearate, Hypromelloses, Polyethylene Glycol 400, Titanium Dioxide, Ferric Oxide Yellow
Also distributed by
Direct_rx, A-S Medication Solutions, Proficient Rx LP, Rpk Pharmaceuticals, Inc., Asclemed Usa, Inc., Pd-Rx Pharmaceuticals, Inc., Nucare Pharmaceuticals, Inc., Coupler LLC, Remedyrepack Inc., Accord Healthcare, Inc., Bryant Ranch Prepack
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
J 7
Prochlorperazine Maleate 10 mg
Yellow, round, 8 mm
Used for anxiety and schizophrenia
-
J 5
Prochlorperazine Maleate 5 mg
Yellow, round, 7 mm
Used for anxiety and schizophrenia
-
P100
Carbamazepine 100 mg
Yellow, round, 8 mm
Used for PTSD and bipolar disorder
-
APO F50
Fluvoxamine Maleate 50 mg
Yellow, round, 9 mm
Used for depression and panic disorder
-
497
Zolmitriptan 2.5 mg
Yellow, round, 7 mm
Used for migraine
-
254 G
Ropinirole 0.5 mg
Yellow, round, 8 mm
Used for Parkinson's disease
Other Spironolactone pills
-
662
Spironolactone 100 mg
White, round, 11 mm
Used for high blood pressure and heart failure
-
AN 515
Spironolactone 100 mg
Brown, round, 11 mm
Used for high blood pressure and heart failure
-
AN 511
Spironolactone 25 mg
White, round, 7 mm
Used for high blood pressure and heart failure
-
660
Spironolactone 25 mg
White, round, 7 mm
Used for high blood pressure and heart failure
-
AN 514
Spironolactone 50 mg
Yellow, round, 9 mm
Used for high blood pressure and heart failure
-
661
Spironolactone 50 mg
White, oval, 11 mm
Used for high blood pressure and heart failure
- 58 82 V Spironolactone 100 mg White, round, 12 mm Used for high blood pressure and heart failure
- R 673 Spironolactone 100 mg White, round, 17 mm Used for high blood pressure and heart failure